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Follicular psoriasis -dermoscopic features at a glance
Sir, A
34-year-old-female presented with multiple asymptomatic-to-mildly itchy skin-colored-to-reddish elevated lesions involving both her lower limbs for last 2 months. There was no history suggestive of upper respiratory, gastrointestinal or urinary tract infection. She denied any history of prior drug intake, scalp scaling, joint pain or swelling, or palmo-plantar thickening. Cutaneous examination revealed multiple discrete, erythematous follicular scaly papules over her both thighs and lower legs [ Figure 1 ]. Mucosa, nails, scalp, palms, and soles were spared. All systemic examinations were within normal limits. Follicular psoriasis, malassezia folliculitis, and follicular lichen planus were considered as the differentials. Dermoscopic examination under nonpolarized contact dermoscopy (Heine Delta20® Dermatoscope, 10× magnification) revealed a white-brown background/homogenous area, normal looking terminal hair at the centre, perifollicular scaling, multiple red dots/dotted vessels, red globules, twisted red loops, and glomerular vessels/ bushy capillaries [ Figure 2 ]. Histopathological examination of a papule revealed a dilated follicular opening, parakeratotic follicular plugging, follicular hyperkeratosis, perifollicular confluent parakeratosis, hypogranulosis, Munro-micro abscess, suprapapillary thinning, upper dermal dilated and tortuous blood vessels, and mild perivascular lympho-histiocytic and neutrophilic infiltration [ Figure 3 ]. Based on these findings, a diagnosis of follicular psoriasis was made and the patient was advised treatment with a topical application of a combination of calcipotriol (0.005% w/w) and clobetasol (0.05% w/w) ointment.
Follicular psoriasis is an under-recognized entity that affects adults more commonly than children without any sexual predilection. Amongst the two clinical subtypes, the adult form commonly affects females and presents as multiple, discrete, follicle-based, hyperkeratotic papules predominantly over the thigh, as in our case. The second type commonly affects children and present as asymmetric, grouped, follicular, keratotic papules predominantly affecting the trunk, axilla, and extensor aspect of limbs. 1 The role of dermoscopy as a diagnostic tool is gaining importance with time as more diseases are being reported where dermoscopy can play a role not only in their diagnosis but also in monitoring their course. To the best of our knowledge dermoscopic features of follicular psoriasis have not yet been reported in the literature. The various dermoscopic features described for plaque psoriasis are white scale, symmetrically and regularly distributed dotted The dermoscopic features described for various follicular dermatoses that may mimic follicular psoriasis (especially the second type) are keratosis pilaris (irregular twisted or coiled vellus hair embedded in the horny layer, perifollicular erythema, scaling, and pigmentation), follicular lichen planus (follicular plug without broken or twisted hairs), pityriasis rubra pilaris (white keratotic plug, yellow peripheral keratotic ring, perifollicular erythema, and linear vessels), scurvy (whitish hair follicles with "corkscrew" hair surrounded by a hemorrhagic violaceous halo), and perforating folliculitis (central white clod surrounded by structureless gray area and brown reticular lines under polarized dermoscopy). [4] [5] [6] [7] The presence of central keratotic plug along with altered hair morphology (twisted or coiled or broken hair) has been described for disorders of abnormal keratinization such as pityriasis rubra pilaris, keratosis pilaris, and scurvy. The presence of vascular pattern, such as diffuse dotted and glomerular vessels, may help in differentiating follicular psoriasis from these disorders. The perifollicular white homogenous area [asterix, Figure 2 ] histologically corresponds to the follicular and perifollicular hyperkeratosis and acanthosis [ Figure 3 ], perifollicular white scale to the perifollicular parakeratosis [ Figure 3 ] and the dotted and nondotted vessels to the dilated and tortuous dermal blood vessels oriented at different angles to the surface of the skin.
To conclude, the presence of central normal looking terminal hair, perifollicular white scale and homogenous area, and vascular structures such as diffuse dotted, twisted or glomerular vessels may help in differentiating follicular psoriasis from its clinical mimics.
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Development of dysplastic nevus during radotinib therapy in patients with chronic myeloid leukemia
Sir, Radotinib is a selective BCR-ABL tyrosine kinase inhibitor (TKI) developed for the treatment of chronic myeloid leukemia (CML).
Recently, a phase III clinical trial of radotinib has shown good clinical efficacy and safety in the treatment for this condition. 1 We were unable to find any report describing dysplastic nevus associated with radotinib therapy. Herein, we report three cases of eruptive melanocytic nevi (EMN) with dysplastic change in patients with chronic myeloid leukemia, highlighting the possibility of dysplastic nevus after treatment with radotinib.
Patient 1 was a 35-year-old male with chronic myeloid leukemia, who began treatment with 800 mg of radotinib in 2013. The patient noticed an increase in the number of pigmented lesions over 1 year. Among them, an atypical pigmented macule on his face exhibited a 5-mm-sized flat surface and asymmetric irregular borders with variable pigmentation [ Figure 1 ]. Patient 2 was a 59-year-old man diagnosed with chronic myeloid leukemia in 2013 who began treatment with 600 mg radotinib in 2015. One month after treatment with radotinib, he noticed new pigmented macules over his entire body. On physical examination, numerous nevi were observed. Among them, a pigmented macule with asymmetric, irregular, and fuzzy borders was noticed on his face [ Figure 2 ]. Patient 3 was a 25-year-old man with chronic myeloid leukemia who was prescribed radotinib since 2013. Six months after treatment with radotinib, multiple eruptive nevi with atypical irregular macules were observed on his face and arms [ Figure 3 ]. All three patients did not receive any immunosuppressive therapies other than radotinib during the therapy. Figure 9 ]. In addition, prominent c-kit immunostaining was also observed [ Figure 9 ]. Based on the clinical, dermoscopic, and histopathological evidence [ Table 1 ], the three patients were given a final diagnosis of dysplastic nevus with eruptive melanocytic nevi, that developed during radotinib therapy.
Eruptive melanocytic nevi can be associated with various conditions including drug-induced, immunosuppression, and local trauma. 2 The proposed mechanisms for these nevi are not well known; however, some suggest that multiple foci of stimulation or immunosuppression potentially result in disarray in the regulation of melanocyte growth and affect the growth of pigmented lesions. Moreover, the conditions associated with the development of eruptive nevi can also be related to the development of dysplastic nevus. 2
The tyrosine kinase inhibitors inhibit not only BCR-ABL but also c-kit signalling pathway. 1 Therefore, a well-recognized adverse pigmentary change associated with imatinib is diffuse hypopigmentation. Because the c-kit signalling pathway along with stem cell factors plays an important role in the development of melanocytes, treatment with tyrosine kinase inhibitors results in a significantly decreased number of melanocytes with high tyrosine kinase activity.
However, paradoxical hyperpigmentation has been reported in imatinib and nilotinib-treated patients. 3 In addition, there has been two case reports describing radotinib-induced pigmentary changes, which reported the development of eruptive melanocytic nevi 4 and lentigines. 5 Although the precise mechanism of action for this paradoxical hyperpigmentation has not yet been experimentally demonstrated, we suspect that pigmentary changes after radotinib might be associated with aberrant activation of c-kit in a specific mutant type. Moreover, because
